Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital

BACKGROUND: We previously reported an increase in meropenem prescriptions for Pseudomonas aeruginosa infections in our hospital after the implementation of the 10th version of the EUCAST breakpoints table for P. aeruginosa in January 2020. As a consequence, antibiotic susceptibility testing results...

Descripción completa

Detalles Bibliográficos
Autores principales: Munting, Aline, Damas, José, Viala, Benjamin, Prod’hom, Guy, Guery, Benoit, Senn, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805013/
https://www.ncbi.nlm.nih.gov/pubmed/36585736
http://dx.doi.org/10.1186/s13756-022-01203-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805013/
https://www.ncbi.nlm.nih.gov/pubmed/36585736
http://dx.doi.org/10.1186/s13756-022-01203-x

Ejemplares similares